While ALK mutations are typically associated with benign or low malignant potential in IMT (4, 5), the mutation in this case is situated in a cancer hotspot region, suggesting a potential risk of malignant transformation. This evidence concerns the gene ALK and inflammatory myofibroblastic tumor.